Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

The effect of SGLT2 inhibition on immune cells and transplant rejection/failure: A drug-targeted mendelian randomization study

Submitted by Anna Hakala on Wed, 04/08/2026 - 14:08
  • Read more about The effect of SGLT2 inhibition on immune cells and transplant rejection/failure: A drug-targeted mendelian randomization study

Genetic evidence for causal roles of circulating proteins on breast cancer susceptibility

Submitted by Anna Hakala on Wed, 04/08/2026 - 14:07
  • Read more about Genetic evidence for causal roles of circulating proteins on breast cancer susceptibility

Genetic pharmacoepidemiology of JAK inhibitors in chronic immune-mediated skin diseases: implications for precision therapy and medication safety

Submitted by Anna Hakala on Wed, 04/08/2026 - 14:06
  • Read more about Genetic pharmacoepidemiology of JAK inhibitors in chronic immune-mediated skin diseases: implications for precision therapy and medication safety

Interplay between genetically predicted gut microbiota and chronic apical periodontitis: a Mendelian randomization analysis

Submitted by Anna Hakala on Wed, 04/08/2026 - 14:04
  • Read more about Interplay between genetically predicted gut microbiota and chronic apical periodontitis: a Mendelian randomization analysis

Hyperthyroidism drives gout risk: A Mendelian randomization observational study

Submitted by Anna Hakala on Wed, 04/08/2026 - 14:00
  • Read more about Hyperthyroidism drives gout risk: A Mendelian randomization observational study

Protective Causal Effects of CCL19, CCL23, and IL17A on Achilles Tendinitis: Insights from Bidirectional Mendelian Randomization and Metabolite-Mediated Pathway Analysis

Submitted by Anna Hakala on Wed, 04/08/2026 - 13:59
  • Read more about Protective Causal Effects of CCL19, CCL23, and IL17A on Achilles Tendinitis: Insights from Bidirectional Mendelian Randomization and Metabolite-Mediated Pathway Analysis

Metabolic-Renal Disease Genetics Architecture Revealed by Genomic Structural Equation Modeling

Submitted by Anna Hakala on Wed, 04/08/2026 - 12:19
  • Read more about Metabolic-Renal Disease Genetics Architecture Revealed by Genomic Structural Equation Modeling

The gut microbiota and plasma metabolites on functional dyspepsia: a study integrating Mendelian randomization and experimental validation

Submitted by Anna Hakala on Wed, 04/08/2026 - 12:18
  • Read more about The gut microbiota and plasma metabolites on functional dyspepsia: a study integrating Mendelian randomization and experimental validation

A Risk Factor Atlas for Allergy-Related Airway Diseases: Evidence From Multi-Biobank Genetic Study

Submitted by Anna Hakala on Wed, 04/08/2026 - 12:17
  • Read more about A Risk Factor Atlas for Allergy-Related Airway Diseases: Evidence From Multi-Biobank Genetic Study

Causal Associations of Cerebrospinal Fluid and Circulating Metabolites With Malignant Brain Neoplasms: A Mendelian Randomization Analysis

Submitted by Anna Hakala on Wed, 04/08/2026 - 12:16
  • Read more about Causal Associations of Cerebrospinal Fluid and Circulating Metabolites With Malignant Brain Neoplasms: A Mendelian Randomization Analysis

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement